
BioCardia IncQ) expected to post a loss of 50 cents a share - Earnings Preview

I'm PortAI, I can summarize articles.
BioCardia IncQ) is anticipated to report a loss of 50 cents per share for the quarter ending June 30, 2025, with a decline in revenue. The sole analyst rating is a "buy," and the mean earnings estimate has remained unchanged over the past three months. Wall Street's median 12-month price target for the company is $15.50, representing a potential increase of 89.2% from its last closing price of $1.68.
- BioCardia Inc (BCDA.OQ) (BCDA.O) is expected to show a fall in quarterly revenue when it reports results on August 11 for the period ending June 30 2025
- LSEG’s mean analyst estimate for BioCardia Inc is for a loss of 50 cents per share.
- The one available analyst rating on the shares is “buy”.
- The mean earnings estimate of analysts was unchanged in the last three months.
- Wall Street’s median 12-month price target for BioCardia Inc is $15.50, about 89.2% above its last closing price of $1.68 This summary was machine generated August 8 at 12:52 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
